<DOC>
	<DOCNO>NCT00841152</DOCNO>
	<brief_summary>This study design perform head-to-head comparison two synthetic ceramic bone graft substitute , bioactive glass ( BAG ) beta-tricalcium phosphate ( TCP ) , fill contain bone defect follow surgical evacuation benign bone tumor tumor-like condition . Based investigator ' previous preclinical research ongoing single-center randomized clinical trial bioactive glass filling , investigator expect BAG fill efficient compare TCP promotion defect heal functional recovery surgery .</brief_summary>
	<brief_title>Comparison Bioactive Glass Beta-Tricalcium Phosphate Bone Graft Substitute</brief_title>
	<detailed_description>This study design perform head-to-head comparison two synthetic ceramic bone graft substitute , bioactive glass ( BAG ) beta-tricalcium phosphate ( TCP ) , fill contain bone defect follow surgical evacuation benign bone tumor tumor-like condition . Small metacarpal phalangeal enchondroma ( Stratum I ) large long-bone lesion ( Stratum II ) evaluate separately . Aside head-to-head comparison two synthetic bone graft substitute , autologous bone graft ( Stratum I ) allogeneic bone graft ( Stratum II ) use standard care control .</detailed_description>
	<mesh_term>Bone Neoplasms</mesh_term>
	<mesh_term>Methamphetamine</mesh_term>
	<criteria>Patients primary recurrent benign bone tumor tumorlike condition require operative treatment mean tumor evacuation defect fill Pathological fracture patient Stratum I treat mean conservative treatment three month tumor surgery History acute chronic local infection History malignancy ( exclude carcinoma basocellular ) within past 5 year A history local radiotherapy A know metabolic skeletal disease ( osteoporosis , Paget 's disease osteomalacia ) Medication affect bone turnover ( oral bisphosphonates , PTH , sodium fluoride , strontium ranelate , calcitonin , testosterone , systemic cortico anabolic steroid ) Any plan use phenol chemical/thermal method local tumor control Pregnancy Any condition judgment investigator , would prohibit subject participate study may hinder collection data interpretation result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Bone tumor</keyword>
	<keyword>Surgery</keyword>
	<keyword>Bone graft substitute</keyword>
	<keyword>Bioactive glass</keyword>
	<keyword>Bioceramics</keyword>
	<keyword>Bone autograft</keyword>
	<keyword>Bone allograft</keyword>
</DOC>